TGEN: Tecogen Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Tecogen Inc (TGEN).
$36.41M Market Cap.
TGEN Market Cap. (MRY)
TGEN Shares Outstanding (MRY)
TGEN Assets (MRY)
Total Assets
$31.09M
Total Liabilities
$20.97M
Total Investments
$0
TGEN Income (MRY)
Revenue
$22.62M
Net Income
-$4.76M
Operating Expense
$14.40M
TGEN Cash Flow (MRY)
CF Operations
$4.06M
CF Investing
-$1.01M
CF Financing
$1.01M
TGEN Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $31,092,259 (11.87%) | $27,792,629 (-1.63%) | $28,252,857 (-12.70%) | $32,362,222 (7.61%) |
Assets Current | $22,145,246 (9.06%) | $20,305,344 (-7.83%) | $22,030,608 (-11.79%) | $24,974,749 (12.53%) |
Assets Non-Current | $8,947,013 (19.50%) | $7,487,285 (20.33%) | $6,222,249 (-15.77%) | $7,387,473 (-6.24%) |
Goodwill & Intangible Assets | $4,859,755 (-6.18%) | $5,179,654 (52.17%) | $3,403,750 (-5.11%) | $3,587,179 (-4.76%) |
Shareholders Equity | $10,230,345 (-30.63%) | $14,746,596 (-22.77%) | $19,094,310 (-9.97%) | $21,208,088 (22.52%) |
Property Plant & Equipment Net | $3,920,784 (86.18%) | $2,105,860 (-20.63%) | $2,653,269 (-27.35%) | $3,652,154 (-6.75%) |
Cash & Equivalents | $5,405,233 (300.01%) | $1,351,270 (-29.40%) | $1,913,969 (-47.05%) | $3,614,463 (142.55%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $7,867,082 (290.07%) | $2,016,817 (35.59%) | $1,487,450 (-31.33%) | $2,166,208 (53.69%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $9,634,005 (-8.71%) | $10,553,419 (0.67%) | $10,482,729 (35.00%) | $7,764,989 (8.32%) |
Trade & Non-Trade Receivables | $6,425,443 (-19.62%) | $7,993,868 (-6.17%) | $8,519,452 (-27.44%) | $11,740,475 (-9.26%) |
Trade & Non-Trade Payables | $4,142,678 (-8.23%) | $4,514,415 (38.40%) | $3,261,952 (-7.02%) | $3,508,354 (-16.13%) |
Accumulated Retained Earnings (Deficit) | -$47,639,894 (-11.10%) | -$42,879,656 (-12.01%) | -$38,281,548 (-6.83%) | -$35,833,621 (9.35%) |
Tax Assets | $0 (0%) | $46,148 (-93.53%) | $713,269 (-44.10%) | $1,276,021 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $3,731,924 (152.45%) | $1,478,285 (115.00%) | $687,589 (7.27%) | $641,002 (-82.21%) |
Debt Current | $2,064,900 (159.74%) | $794,978 (15.62%) | $687,589 (7.27%) | $641,002 (-52.32%) |
Debt Non-Current | $1,667,024 (143.96%) | $683,307 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $20,966,721 (59.56%) | $13,140,334 (41.83%) | $9,265,107 (-17.53%) | $11,234,073 (-12.28%) |
Liabilities Current | $16,815,596 (60.41%) | $10,482,798 (36.38%) | $7,686,320 (-12.47%) | $8,780,868 (-4.25%) |
Liabilities Non-Current | $4,151,125 (56.20%) | $2,657,536 (68.33%) | $1,578,787 (-35.64%) | $2,453,205 (-32.52%) |
TGEN Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $22,619,536 (-10.02%) | $25,139,419 (0.55%) | $25,002,614 (2.48%) | $24,398,073 (-13.65%) |
Cost of Revenue | $12,749,363 (-14.65%) | $14,937,801 (7.19%) | $13,935,803 (8.78%) | $12,810,420 (-26.49%) |
Selling General & Administrative Expense | $13,237,309 (-4.16%) | $13,811,426 (8.58%) | $12,720,336 (3.69%) | $12,267,752 (-4.93%) |
Research & Development Expense | $961,837 (14.50%) | $840,011 (14.62%) | $732,873 (35.20%) | $542,079 (-29.35%) |
Operating Expenses | $14,404,260 (-1.44%) | $14,615,230 (8.94%) | $13,415,952 (4.76%) | $12,806,745 (-23.71%) |
Interest Expense | $117,118 (52.00%) | $77,053 (51.18%) | $50,968 (34.18%) | $37,984 (-69.81%) |
Income Tax Expense | $22,565 (-30.55%) | $32,491 (98.70%) | $16,352 (-16.10%) | $19,491 (-35.40%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$4,673,770 (-3.33%) | -$4,523,156 (-88.64%) | -$2,397,712 (-164.09%) | $3,741,017 (160.17%) |
Net Income to Non-Controlling Interests | $86,468 (15.36%) | $74,952 (49.26%) | $50,215 (11.55%) | $45,017 (167.51%) |
Net Income | -$4,760,238 (-3.53%) | -$4,598,108 (-87.84%) | -$2,447,927 (-166.23%) | $3,696,000 (160.09%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$4,760,238 (-3.53%) | -$4,598,108 (-87.84%) | -$2,447,927 (-166.23%) | $3,696,000 (160.09%) |
Weighted Average Shares | $24,861,190 (0.04%) | $24,850,261 (0.00%) | $24,850,261 (0.00%) | $24,850,261 (0.00%) |
Weighted Average Shares Diluted | $24,861,190 (0.04%) | $24,850,261 (0.00%) | $24,850,261 (-1.06%) | $25,115,518 (1.07%) |
Earning Before Interest & Taxes (EBIT) | -$4,620,555 (-2.94%) | -$4,488,564 (-88.55%) | -$2,380,607 (-163.42%) | $3,753,475 (162.62%) |
Gross Profit | $9,870,173 (-3.25%) | $10,201,618 (-7.82%) | $11,066,811 (-4.49%) | $11,587,653 (7.02%) |
Operating Income | -$4,534,087 (-2.73%) | -$4,413,612 (-87.88%) | -$2,349,141 (-92.70%) | -$1,219,092 (79.55%) |
TGEN Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$1,014,737 (-314.37%) | -$244,889 (29.74%) | -$348,565 (-62.08%) | -$215,058 (1.24%) |
Net Cash Flow from Financing | $1,008,153 (101.63%) | $500,000 (0%) | $0 (0%) | $1,874,269 (424.87%) |
Net Cash Flow from Operations | $4,060,547 (596.51%) | -$817,810 (39.51%) | -$1,351,929 (-390.72%) | $465,033 (-66.95%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $4,053,963 (820.45%) | -$562,699 (66.91%) | -$1,700,494 (-180.05%) | $2,124,244 (246.79%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | -$170,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$96,974 (-54.68%) | -$62,693 (18.41%) | -$76,836 (-8.23%) | -$70,996 (-16.59%) |
Capital Expenditure | -$917,763 (-7425.11%) | -$12,196 (94.96%) | -$242,224 (-199.17%) | -$80,965 (-140.85%) |
Issuance (Repayment) of Debt Securities | $937,153 (87.43%) | $500,000 (0%) | $0 (0%) | $1,874,269 (424.20%) |
Issuance (Purchase) of Equity Shares | $71,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $172,987 (-30.91%) | $250,394 (-25.07%) | $334,149 (65.07%) | $202,431 (6.02%) |
Depreciation Amortization & Accretion | $553,783 (-2.45%) | $567,712 (32.54%) | $428,348 (-8.83%) | $469,854 (13.46%) |
TGEN Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 43.60% (7.39%) | 40.60% (-8.35%) | 44.30% (-6.74%) | 47.50% (24.02%) |
Profit Margin | -21.00% (-14.75%) | -18.30% (-86.73%) | -9.80% (-164.90%) | 15.10% (169.27%) |
EBITDA Margin | -18.00% (-15.38%) | -15.60% (-100.00%) | -7.80% (-145.09%) | 17.30% (187.37%) |
Return on Average Equity (ROAE) | -40.20% (-44.09%) | -27.90% (-132.50%) | -12.00% (-165.57%) | 18.30% (161.20%) |
Return on Average Assets (ROAA) | -16.70% (-4.38%) | -16.00% (-97.53%) | -8.10% (-169.83%) | 11.60% (165.91%) |
Return on Sales (ROS) | -20.40% (-13.97%) | -17.90% (-88.42%) | -9.50% (-161.69%) | 15.40% (172.64%) |
Return on Invested Capital (ROIC) | -43.20% (-27.06%) | -34.00% (-131.29%) | -14.70% (-175.00%) | 19.60% (169.26%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -7.71 (-80.88%) | -4.26 (65.90%) | -12.5 (-256.25%) | 8 (263.93%) |
Price to Sales Ratio (P/S) | 1.61 (101.00%) | 0.8 (-35.51%) | 1.24 (1.64%) | 1.22 (13.89%) |
Price to Book Ratio (P/B) | 3.56 (160.73%) | 1.36 (-16.10%) | 1.63 (15.72%) | 1.41 (-19.70%) |
Debt to Equity Ratio (D/E) | 2.05 (129.97%) | 0.89 (83.71%) | 0.48 (-8.49%) | 0.53 (-28.38%) |
Earnings Per Share (EPS) | -0.19 (0.00%) | -0.19 (-90.00%) | -0.1 (-166.67%) | 0.15 (160.00%) |
Sales Per Share (SPS) | 0.91 (-10.08%) | 1.01 (0.60%) | 1.01 (2.44%) | 0.98 (-13.63%) |
Free Cash Flow Per Share (FCFPS) | 0.13 (481.82%) | -0.03 (48.44%) | -0.06 (-526.67%) | 0.01 (-72.73%) |
Book Value Per Share (BVPS) | 0.41 (-30.69%) | 0.59 (-22.79%) | 0.77 (-9.96%) | 0.85 (22.38%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.05 (15.93%) | 0.91 (-9.00%) | 1 (-13.64%) | 1.16 (9.35%) |
Enterprise Value Over EBIT (EV/EBIT) | -8 (-100.00%) | -4 (66.67%) | -12 (-271.43%) | 7 (240.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -9.57 (-89.10%) | -5.06 (65.75%) | -14.78 (-330.41%) | 6.42 (210.49%) |
Asset Turnover | 0.79 (-9.38%) | 0.87 (6.07%) | 0.82 (7.85%) | 0.76 (-5.56%) |
Current Ratio | 1.32 (-32.01%) | 1.94 (-32.41%) | 2.87 (0.77%) | 2.84 (17.52%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $3,142,784 (478.65%) | -$830,006 (47.93%) | -$1,594,153 (-515.07%) | $384,068 (-72.04%) |
Enterprise Value (EV) | $38,933,655 (96.13%) | $19,850,488 (-31.22%) | $28,859,640 (6.50%) | $27,098,032 (-16.38%) |
Earnings Before Tax (EBT) | -$4,737,673 (-3.77%) | -$4,565,617 (-87.76%) | -$2,431,575 (-165.44%) | $3,715,491 (160.71%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$4,066,772 (-3.72%) | -$3,920,852 (-100.84%) | -$1,952,259 (-146.23%) | $4,223,329 (175.68%) |
Invested Capital | $7,743,599 (-36.82%) | $12,257,192 (-23.09%) | $15,936,407 (-6.37%) | $17,020,714 (-11.58%) |
Working Capital | $5,329,650 (-45.74%) | $9,822,546 (-31.52%) | $14,344,288 (-11.42%) | $16,193,881 (24.34%) |
Tangible Asset Value | $26,232,504 (16.01%) | $22,612,975 (-9.00%) | $24,849,107 (-13.64%) | $28,775,043 (9.38%) |
Market Capitalization | $36,405,632 (80.86%) | $20,128,711 (-35.20%) | $31,062,826 (4.17%) | $29,820,313 (-1.64%) |
Average Equity | $11,853,418 (-28.03%) | $16,468,911 (-19.22%) | $20,388,420 (0.70%) | $20,246,661 (-1.50%) |
Average Assets | $28,546,512 (-0.73%) | $28,755,748 (-5.27%) | $30,355,469 (-4.96%) | $31,940,606 (-8.51%) |
Invested Capital Average | $10,698,795 (-18.93%) | $13,196,311 (-18.29%) | $16,149,814 (-15.62%) | $19,140,412 (-9.64%) |
Shares | 24,850,261 (0.00%) | 24,850,261 (0.00%) | 24,850,261 (0.00%) | 24,850,261 (0.00%) |